Novavax Inc (NASDAQ:NVAX)
| 93.18 Delayed Data As of 4:00pm ET |  -0.51 / -0.54%Today’s Change | 3.54 Today|||52-Week Range 189.40 | +2,241.21% Year-to-Date |
Latest NVAX News | Press Releases
Today’s Trading
| Previous close | 93.69 |
| Today’s open | 93.06 |
| Day’s range | 86.50 - 93.18 |
| Volume | 70,110 |
| Average volume (3 months) | 6,724,071 |
| Market cap | $6.6B |
Data as of 4:00pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | +44.90% |
| Earnings growth (this year) | +265.07% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -45.57% |
| P/E ratio | NM |
| Price/Sales | 5.14 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BPMCBlueprint Medicines ... | +2.04 | +1.98% |
| ARWRArrowhead Pharmaceut... | +0.27 | +0.46% |
| IOVAIovance Biotherapeut... | +0.92 | +2.51% |
| ---- |
Data as of 4:00pm ET, 10/23/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | $1.73 |
| Annual revenue (last year) | $18.7M |
| Annual profit (last year) | -$132.7M |
| Net profit margin | -711.04% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
